Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b

Por Engkvist, M. E., Stratford, E. W., Lorenz, S., Meza-Zepeda, L. A., Myklebost, O., Munthe, E.
Publicado no Sci Rep (2017)

Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.

Por Forus, A., Berner, J. M., Meza-Zepeda, L. A., Saeter, G., Mischke, D., Fodstad, O., Myklebost, O.
Publicado em 1998

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes

Por Lauvrak, S U, Munthe, E, Kresse, S H, Stratford, E W, Namløs, H M, Meza-Zepeda, L A, Myklebost, O
Publicado em 2013

High number of kinome‐mutations in non‐small cell lung cancer is associated with reduced immune response and poor relapse‐free survival

Por Helland, Å., Brustugun, O. T., Nakken, S., Halvorsen, A. R., Dønnem, T., Bremnes, R., Busund, L. T., Sun, J., Lorenz, S., Solberg, S. K., Jørgensen, L. H., Vodak, D., Myklebost, O., Hovig, E., Meza‐Zepeda, L. A.
Publicado no Int J Cancer (2017)

BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis

Por Rustad, E H, Dai, H Y, Hov, H, Coward, E, Beisvag, V, Myklebost, O, Hovig, E, Nakken, S, Vodák, D, Meza-Zepeda, L A, Sandvik, A K, Wader, K F, Misund, K, Sundan, A, Aarset, H, Waage, A
Publicado no Blood Cancer J (2015)